Genelux Corporation
Genelux Corporation is a privately-held, clinical-stage biopharmaceutical company that is primarily focused on the development of oncolytic virotherapy and tumor imaging technologies for the treatment of cancer. The company was founded in 2001 and is headquartered in San Diego, California, United States.
History[edit | edit source]
Genelux Corporation was established in 2001 with the aim of developing innovative, proprietary oncolytic virotherapy and tumor imaging technologies. The company's research and development efforts are primarily focused on the creation of novel oncolytic viruses that can selectively replicate in cancer cells, leading to their destruction, while sparing healthy cells.
Oncolytic Virotherapy[edit | edit source]
Oncolytic virotherapy is a form of cancer therapy that uses viruses to infect and kill cancer cells. Genelux Corporation's oncolytic virotherapy platform is based on the Vaccinia virus, which has a natural propensity for infecting cancer cells. The company has engineered the virus to enhance its cancer-killing abilities and to express biomarkers that allow for the non-invasive imaging of the virus in the body.
Tumor Imaging[edit | edit source]
In addition to its oncolytic virotherapy platform, Genelux Corporation has developed a tumor imaging technology that allows for the non-invasive visualization of tumors in the body. This technology is based on the expression of biomarkers by the company's engineered Vaccinia virus, which can be detected using standard imaging techniques.
Clinical Trials[edit | edit source]
Genelux Corporation has conducted several clinical trials to evaluate the safety and efficacy of its oncolytic virotherapy and tumor imaging technologies. These trials have involved patients with various types of cancer, including melanoma, head and neck cancer, and colorectal cancer.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
